Latest Articles

Publication Date
Evaluation of One Step Nucleic Acid Amplification for detection of lymph node metastases compared to histopathological ultrastaging in women with endometrial cancer: a protocol for a diagnostic accuracy study - bmcwomenshealth.biomedcentral.com

Evaluation of One Step Nucleic Acid Amplification for detection of lymph node metastases compared to histopathological ultrastaging in women with endometrial cancer: a protocol for a diagnostic accuracy study bmcwomenshealth.biomedcentral.com

Published: Jan. 9, 2025, 1:36 a.m.
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy - Frontiers

Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy Frontiers

Published: Jan. 6, 2025, 6:36 p.m.
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature - Cureus

Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature Cureus

Published: Jan. 5, 2025, 6:05 a.m.
Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer - Physician's Weekly

Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer Physician's Weekly

Published: Dec. 31, 2024, 12:27 p.m.
Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer - Frontiers

Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer Frontiers

Published: Dec. 30, 2024, 11:50 p.m.
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - BioMed Central

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery BioMed Central

Published: Dec. 30, 2024, 4:33 a.m.
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - bmcwomenshealth.biomedcentral.com

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery bmcwomenshealth.biomedcentral.com

Published: Dec. 30, 2024, 4:33 a.m.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!